A randomized phase III trial of adjuvant chemotherapy with cisplatin and vindesine followed by UFT for completely resected pathologic (p-) stage IIIA-N2 non-small cell lung cancer (NSCLC): West Japan Study Group for Lung Cancer Surgery (WJSG) - the 5th Study
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7262-7262
◽
Keyword(s):